Hydroxypropyl Cellulose for Drug Precipitation Inhibition: From the Potential of Molecular Interactions to Performance Considering Microrheology

dc.accessRightsAnonymous*
dc.contributor.authorStoyanov, Edmont
dc.contributor.authorNiederquell, Andreas
dc.contributor.authorKuentz, Martin
dc.date.accessioned2022-10-12T10:38:56Z
dc.date.available2022-10-12T10:38:56Z
dc.date.issued2022-01-10
dc.description.abstractThere has been recent interest in using hydroxypropyl cellulose (HPC) for supersaturating drug formulations. This study investigated the potential for molecular HPC interactions with the model drug celecoxib by integrating novel approaches in the field of drug supersaturation analysis. Following an initial polymer characterization study, quantum-chemical calculations and molecular dynamics simulations were complemented with results of inverse gas chromatography and broadband diffusing wave spectroscopy. HPC performance was studied regarding drug solubilization and kinetics of desupersaturation using different grades (i.e., HPC-UL, SSL, SL, and L). The results suggested that the potential contribution of dispersive interactions and hydrogen bonding depended strongly on the absence or presence of the aqueous phase. It was proposed that aggregation of HPC polymer chains provided a complex heterogeneity of molecular environments with more or less excluded water for drug interaction. In precipitation experiments at a low aqueous polymer concentration (i.e., 0.01%, w/w), grades L and SL appeared to sustain drug supersaturation better than SSL and UL. However, UL was particularly effective in drug solubilization at pH 6.8. Thus, a better understanding of drug–polymer interactions is important for formulation development, and polymer blends may be used to harness the combined advantages of individual polymer grades.en_US
dc.identifier.doi10.1021/acs.molpharmaceut.1c00832
dc.identifier.issn1543-8384
dc.identifier.issn1543-8392
dc.identifier.urihttps://doi.org/10.1021/acs.molpharmaceut.1c00832
dc.identifier.urihttps://irf.fhnw.ch/handle/11654/33942
dc.issue2en_US
dc.language.isoenen_US
dc.publisherAmerican Chemical Societyen_US
dc.relation.ispartofMolecular Pharmaceuticsen_US
dc.spatialWashingtonen_US
dc.subjectbioenabling formulationen_US
dc.subjectsolid dispersionen_US
dc.subjectsupersaturationen_US
dc.subjectprecipitation inhibitionen_US
dc.subjecthydroxypropyl celluloseen_US
dc.subjectmolecular dynamics simulationen_US
dc.subjectmicrorheologyen_US
dc.subject.ddc500 - Naturwissenschaftenen_US
dc.titleHydroxypropyl Cellulose for Drug Precipitation Inhibition: From the Potential of Molecular Interactions to Performance Considering Microrheologyen_US
dc.type01A - Beitrag in wissenschaftlicher Zeitschrift
dc.volume19en_US
dspace.entity.typePublication
fhnw.InventedHereYesen_US
fhnw.IsStudentsWorknoen_US
fhnw.ReviewTypeAnonymous ex ante peer review of a complete publicationen_US
fhnw.affiliation.hochschuleHochschule für Life Sciences FHNWde_CH
fhnw.affiliation.institutInstitut für Pharma Technologyde_CH
fhnw.openAccessCategoryCloseden_US
fhnw.pagination690-703en_US
fhnw.publicationStatePublisheden_US
relation.isAuthorOfPublication06a3358a-d47d-4c9a-8527-ca95e717ed66
relation.isAuthorOfPublication68819448-8611-488b-87bc-1b1cf9a6a1b4
relation.isAuthorOfPublication.latestForDiscovery68819448-8611-488b-87bc-1b1cf9a6a1b4
Dateien

Lizenzbündel

Gerade angezeigt 1 - 1 von 1
Kein Vorschaubild vorhanden
Name:
license.txt
Größe:
1.37 KB
Format:
Item-specific license agreed upon to submission
Beschreibung: